Drug intelligence / Profile preview

malpighia emarginata extract

Development stage
Unknown
Administration
Oral, Topical
01

Overview

Malpighia emarginata extract is a plant-derived substance obtained from the ripe fruit of Malpighia emarginata, commonly known as acerola or Barbados cherry. The extract is exceptionally rich in vitamin C (ascorbic acid), along with other bioactive compounds such as polyphenols, carotenoids (like β-carotene), flavonoids (including naringenin and catechins), and anthocyanins. It is widely used as a dietary supplement ingredient for its antioxidant properties and immune-boosting effects[1][5][8]. In addition to its nutritional uses, Malpighia emarginata extract has demonstrated anti-inflammatory activity by lowering pro-inflammatory cytokines such as TNF-α[1]. The mechanism of action primarily involves antioxidant activity—scavenging free radicals—and modulation of inflammatory pathways. It is also incorporated into cosmetic products for skin and hair conditioning due to its protective effects against environmental stressors[3][5]. There are no specific pharmaceutical developers; it is produced by various manufacturers globally.

Brand names
Acerola Extract
Other names
acerolabarbados cherrymalpighia punicifolia extractmalpighia emarginata (acerola) fruit extract

Beyond the preview

Go deeper on malpighia emarginata extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on malpighia emarginata extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call